The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
基本信息
- 批准号:7769809
- 负责人:
- 金额:$ 22.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-15 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:Axillary Lymph Node DissectionCell ProliferationCellsDataDiseaseDrainage procedureExtracellular MatrixGoalsGrowthGrowth FactorHumanImplantLiquid substanceLymphLymphangiogenesisLymphaticLymphatic CapillariesLymphatic Endothelial CellsLymphedemaMediatingModelingMusNatural regenerationObstructionPhysiologicalRegulationRelative (related person)ReportingResolutionRoleSchemeSiteSkinStagingSwellingTailTestingTissuesVascular Endothelial Growth Factor CVascular Endothelial Growth Factorsangiogenesisarmcancer surgerycell motilitycitrate carrierclinically significantcompare effectivenessimprovedinterstitialmalignant breast neoplasmmouse modeloverexpressionpublic health relevancescaffoldwound
项目摘要
DESCRIPTION (provided by applicant): Vascular endothelial growth factor (VEGF)-C has been shown to be necessary for lymphangiogenesis and may be useful for lymphangiogenic therapy in diseases of inadequate lymphatic drainage. Although a number of recent studies have reported that overexpression of VEGF-C can promote lymphangiogenesis and improve lymphatic function, we have found that the ability of excess lymphatic growth factor alone to increase functional lymphatic growth above physiological levels may be limited. We have also found that experimental lymphedema is able to resolve in the absence of lymphangiogenesis. Clinically, compressive garments have been shown to produce significant reductions in the swelling of the edematous human arm. These results suggest that interstitial flow (IF) dynamics across the obstruction site may be important for resolution of lymphedema and that IF can be increased in the edematous arm without prior stimulation of lymphatic growth. Therefore therapies that directly increase IF may be beneficial for lymphedema. It has recently been demonstrated that fluid channels are formed by IF and that endogenous VEGF-C promotes lymphatic endothelial cell (LEC) migration along the fluid channel scaffold during early stages of lymphangiogenesis. We hypothesize that compressive loading may increase IF by increasing fluid channel formation and that combining VEGF-C therapy with compressive loading may improve functional lymphangiogenesis by convecting VEGF-C through fluid channels and establishing VEGF-C gradients that can direct functional lymphatic growth. We aim to determine whether compressive loading may increase IF by increasing the formation of fluid channels, whether an augmentation of fluid channels by compression in conjunction with exogenous VEGF-C protein may enhance functional lymphangiogenesis and improve lymphedema, and whether cyclic compressive loading may increase IF relative to static compressive loading.
PUBLIC HEALTH RELEVANCE: Lymphedema often follows axillary lymph node dissection from breast cancer surgery. Although compression therapy reduces lymphedema, the mechanism of action is not clear. We aim to clarify the role of compression in regulating interstitial flow and to determine the ability of combined compression/lymphangiogenesis therapy to improve lymphedema.
描述(由申请人提供):已证明血管内皮生长因子(VEGF)-C对于淋巴管生成是必需的,对于淋巴引流不足的疾病中的淋巴管疗法可能很有用。尽管许多最近的研究报告说,VEGF-C的过度表达可以促进淋巴管生成并改善淋巴功能,但我们发现,仅过量淋巴生长因子单独增加功能性淋巴生长的能力可能受到限制。我们还发现,在没有淋巴管生成的情况下,实验性淋巴水肿能够解决。在临床上,已显示压缩服会在水肿人臂的肿胀中显着减少。这些结果表明,整个阻塞部位的间质性流动(IF)动力学对于淋巴水肿的分辨率可能很重要,并且如果可以在没有事先刺激淋巴生长的情况下增加水肿臂中的增加。因此,如果可能对淋巴水肿有益,可以直接增加的疗法。最近已经证明,在淋巴管生成的早期阶段,内源性VEGF-C促进了淋巴内皮细胞(LEC)沿流体通道支架迁移的淋巴内皮细胞(LEC)迁移。我们假设,如果通过增加流体通道的形成来增加压缩负荷,并且将VEGF-C治疗与压缩负荷结合使用可以通过通过流体通道对流VEGF-C来改善功能性淋巴管生成并建立可以直接功能淋巴生长的VEGF-C梯度来改善功能性淋巴管生成。我们旨在确定如果通过增加流体通道的形成,是否会增加压缩负荷,是否通过与外源性VEGF-C蛋白结合压缩来增加流体通道的增强,是否可以增强功能性淋巴管菌的发生并改善淋巴结和淋巴水肿,以及如果相对于静态压缩载荷增加,是否会增加循环压缩负荷。
公共卫生相关性:淋巴水肿经常跟随乳腺癌手术中的腋窝淋巴结清扫术。尽管压缩疗法降低了淋巴水肿,但作用机理尚不清楚。我们旨在阐明压缩在调节间质流中的作用,并确定组合压缩/淋巴管生成疗法改善淋巴水肿的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Goldman其他文献
Jeremy Goldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Goldman', 18)}}的其他基金
Biodegradable Metal Stent Alloys for Vascular Applications
用于血管应用的可生物降解金属支架合金
- 批准号:
10643743 - 财政年份:2023
- 资助金额:
$ 22.8万 - 项目类别:
Biodegradation mechanism and rate, biocompatibility, and toxicity for novel Zn-Mg stent materials
新型锌镁支架材料的生物降解机制和速率、生物相容性和毒性
- 批准号:
8957197 - 财政年份:2015
- 资助金额:
$ 22.8万 - 项目类别:
Therapeutic Lymphatic Collecting Vessel Regeneration by Directed Fluid Flow
通过定向流体流进行治疗性淋巴收集管再生
- 批准号:
8287227 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
- 批准号:
8013022 - 财政年份:2010
- 资助金额:
$ 22.8万 - 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
- 批准号:
7141151 - 财政年份:2006
- 资助金额:
$ 22.8万 - 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
- 批准号:
7267942 - 财政年份:2006
- 资助金额:
$ 22.8万 - 项目类别:
Mechanical Stretch and Vein Graft Intimal Hyperplasia
机械拉伸和静脉移植内膜增生
- 批准号:
6952906 - 财政年份:2005
- 资助金额:
$ 22.8万 - 项目类别:
相似国自然基金
POLRMT抑制卵巢癌细胞有氧糖酵解与增殖的作用机制研究
- 批准号:82303216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MOXD1通过协助β3GnT2对EGFR的糖基化修饰调控胶质母细胞瘤的增殖和化疗敏感性
- 批准号:82302984
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
葡萄糖饥饿条件下AMPK-CREB-PPA1信号通路促进非小细胞肺癌细胞增殖的分子机制研究
- 批准号:82360518
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
MEIS1阻滞细胞周期进程抑制结直肠癌增殖的双调节机制研究
- 批准号:82372711
- 批准年份:2023
- 资助金额:45 万元
- 项目类别:面上项目
miR-106b-5p调控增殖niche中肝脏细胞间时空互作介导川楝素肝损伤的适应性反应机制研究
- 批准号:82374136
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Understanding how exocrine-derived signals promote beta cell growth
了解外分泌信号如何促进 β 细胞生长
- 批准号:
10750765 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Decoding AMPK-dependent regulation of DNA methylation in lung cancer
解码肺癌中 DNA 甲基化的 AMPK 依赖性调节
- 批准号:
10537799 - 财政年份:2023
- 资助金额:
$ 22.8万 - 项目类别:
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 22.8万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 22.8万 - 项目类别: